Cephalexin Dosing for Pediatric UTI: 74 lb Child
For a child weighing 74 lb (33.6 kg) with a urinary tract infection, prescribe cephalexin 850 mg (17 mL of the 250 mg/5 mL suspension) given every 12 hours for 7-14 days.
Dosing Calculation
The FDA-approved pediatric dosing for cephalexin is 25-50 mg/kg/day in divided doses 1. For UTIs specifically:
- Weight: 74 lb = 33.6 kg
- Standard dose: 25-50 mg/kg/day divided
- Calculation: 33.6 kg × 25 mg/kg = 840 mg/day (minimum)
- Practical dosing: 850 mg twice daily = 1,700 mg/day total (approximately 50 mg/kg/day)
Using the 250 mg/5 mL suspension:
- 850 mg = 17 mL per dose
- Given every 12 hours (twice daily)
Dosing Schedule Options
The FDA label supports twice-daily dosing for UTIs 1. Recent evidence confirms that cephalexin 500 mg twice daily is as effective as four-times-daily dosing for UTIs in adults 2, and the twice-daily regimen improves adherence without compromising efficacy.
For this 74 lb child, the practical options are:
- Preferred: 850 mg (17 mL) every 12 hours
- Alternative: 425 mg (8.5 mL) every 6 hours if twice-daily dosing is inadequate
Treatment Duration
7-14 days of therapy is recommended for pediatric UTIs 3, 1. The AAP guideline reaffirms this duration range 3. While some studies suggest 3-day courses may be effective for uncomplicated lower UTIs 4, the standard remains 7-14 days, particularly for febrile UTIs.
Important Caveats
- Severe infections: If the UTI is severe or caused by less susceptible organisms, consider increasing to the higher end of the dosing range (up to 100 mg/kg/day divided every 6 hours) 1
- Maximum daily dose: Do not exceed 4 grams per day 1
- Renal function: Ensure normal renal function; dose adjustment may be needed in renal impairment 1
- Culture guidance: Adjust therapy based on urine culture and sensitivity results 3
Practical Prescribing
Prescription: Cephalexin 250 mg/5 mL oral suspension, dispense 240 mL
- Sig: Give 17 mL by mouth every 12 hours for 10 days
- Storage: Refrigerate after reconstitution; discard after 14 days 1
The twice-daily dosing significantly improves adherence compared to four-times-daily regimens, which is critical for treatment success in pediatric patients.